Monday Apr 04, 2022

Episode 2. Centralised and Decentralised Procedures

Different approval pathways can be explored while entering the European pharmaceutical market. The approval pathways include:

  • Centralized Procedure (CP)
  • Decentralized Procedure (DCP)
  • National Procedure (NP)
  • Mutual Recognition Procedure (MRP)

Our experts discuss the most explored pathways, CP and DCP, and the eligibility criteria to pursue them for product approval and marketing authorization within the European Union (EU). 

Reference Links

Comments (0)

To leave or reply to comments, please download free Podbean or

No Comments

Copyright 2022 All rights reserved.

Podcast Powered By Podbean